Facebook
Twitter
LinkedIn
ForwardTransgender Advocacy in Healthcare: Experiences and Empowerment
Overview
| Registration |
|---|
Two attendance options:
|
Target Audience
Healthcare professionals.
Educational Need
Transgender individuals face persistent disparities in healthcare access, quality, and outcomes due to systemic barriers, bias, and a lack of provider education. As both patients and healthcare professionals, transgender individuals often encounter discrimination, inadequate medical training on gender-affirming care, and institutional policies that fail to address their needs.
Healthcare providers must have the knowledge and skills to advocate for systemic change in medical education and healthcare policies. This includes understanding the unique challenges transgender individuals face, fostering inclusive clinical and workplace environments, and championing policies that promote equity and access to quality care.
This educational activity addresses these gaps by empowering participants with the tools to recognize and address healthcare inequities, advocate for policy reforms, and create affirming spaces for transgender individuals. By fostering a culture of inclusion and advocacy, healthcare professionals can drive meaningful improvements in transgender healthcare experiences and outcomes.
Description
This session explores the critical role of advocacy in improving healthcare experiences for transgender individuals, both as patients and providers. Participants will examine the systemic barriers faced by transgender individuals in medical settings and develop strategies to drive meaningful change in healthcare policies and medical education.
Learning Objectives
- Develop strategies to advocate for systemic change in medical education and healthcare policies.
- Discuss the unique challenges faced by transgender individuals as patients and providers.
- Identify strategies for fostering an inclusive and supportive healthcare environment.
Speaker
Charles Adams
4th Year Medical Student, Kansas City University College of Osteopathic Medicine
Location
Des Moines University’s new campus, located at 8025 Grand Avenue in West Des Moines, Iowa, offers an impressive 88 acres, providing ample space for growth and innovation. State-of-the-art facilities cater to the evolving needs of students and faculty, fostering an exceptional learning and research environment. The campus offers a perfect blend of academic excellence and access to the thriving community of Greater Des Moines, including cultural attractions, dining, and entertainment options.
CE Credits
Accreditation Statements
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University Medicine and Health Sciences (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this live activity for 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- DPM: Des Moines University Medicine and Health Sciences (DMU) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. DMU has approved this activity for a maximum of 1.0 continuing education contact hours.
- Nurse: Des Moines University Medicine and Health Sciences is Iowa Board of Nursing approved provider #112. This activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit is awarded.
- Other healthcare providers: This activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.
 |  |
Educational Grants
No ineligible company provided financial support for this continuing education activity.
Disclosure
The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Charles Adams - Speaker
- Rachel Blindell - Planning Committee Member
- Mallory Britz - Planning Committee Member
- Matthew Christensen - Planning Committee Member
- Katherine Hadley - Planning Committee Member
- Helena Mica, PhD - Activity Director and Planning Committee Member
- Hayden Oyler - Planning Committee Member
- Brooke Pierce - Planning Committee Member
- Kimberly Ramos - Planning Committee Member
- James Sizer, M.Ed - Activity Director and Planning Committee Member
- Subeksha Sharma - Planning Committee Member
- Madeline Westendorp - Planning Committee Member
Disclaimer
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 2A
- 1.00 CE Contact Hour(s)
- 1.00 CPME
- 1.00 IBON
Register/Take course
Price
There is no cost to attend.
Two attendance options:
- Des Moines University - No registration is necessary to attend on-site.
- Online - Register through Zoom.